RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.

Int J Mol Sci · 2013 · PMC3709696 · PMID 23702841

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Conclusions In conclusion, the present prospective study highlights a clear trend towards a decrease in the RANK-L/OPG ratio and NTX levels after 12 months of treatment with zoledronic acid.

also in 19,460 other papers

did not reach statistical significanceno p-value reported

These differences, however, did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.